Annual report
9818.TEDINET S100TUYZ
Period2023-04-01 → 2024-03-31
Filed2024-06-27
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥29.9bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥30.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥26.5bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥21.4bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥18.5bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥1.1bn | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥1.0bn | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥1.2bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.1bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.1bn | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.1bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥946m | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.2bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.2bn | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥734m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥661m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥755m | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥671m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥848m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥734m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥687m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥21.8bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥21.8bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥20.2bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥19.4bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥19.4bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.7bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥7.6bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥14.1bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥14.2bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥13.4bn | at 2022-03-31d | Cons. | Net assets |
| Net assets / equity | ¥12.7bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥12.0bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.7bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.6bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.6bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.5bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.1bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.8bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥5.1bn | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥2.3bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.3bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.1bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.7bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.1bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥1.5bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.5bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.2bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.6bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.3bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥981m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥291m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥531m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥445m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.0bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥96.09 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥86.78 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥99.14 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥88.06 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥111.29 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥1,849.89 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,811.07 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,754.24 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,663.56 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,572.8 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 64.8% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.3% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.1% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.2% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.7% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 5.3% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 4.9% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.8% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.4% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.3% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 642 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 614 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 545 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 510 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 497 | at 2020-03-31d | Cons. | Number of employees |
| Revenue | ¥23.3bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥24.6bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥21.6bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥17.1bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥16.6bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥841m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | ¥876m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | ¥930m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥958m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.0bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.1bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥947m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥948m | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥1.1bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | ¥625m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥723m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥750m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥681m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥887m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥19.8bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥18.9bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥18.2bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥17.3bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥16.8bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥5.5bn | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥5.1bn | at 2023-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥14.2bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥13.8bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥13.3bn | at 2022-03-31d | Standalone | Net assets |
| Net assets / equity | ¥12.6bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥11.9bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.5bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.5bn | at 2023-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥81.89 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥94.94 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥98.37 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥89.41 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥116.47 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥25 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥23 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥21 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥20.5 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥18 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,863.91 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,809.66 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,745.23 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,659.1 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,566.95 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 72.0% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.9% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.1% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.9% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.2% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 4.5% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.3% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.8% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.5% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.7% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 8,046,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,046,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,046,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,046,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,046,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 443 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 420 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 407 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 388 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 373 | at 2020-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 56
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥7.4bn |
| Aquareportable segment | capex | 2023-04-01 → 2024-03-31 | ¥46m |
| Aquareportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥46m |
| Aquareportable segment | employees | at 2024-03-31 | 91 pure |
| Aquareportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥1.2bn |
| Aquareportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥1.2bn |
| Aquareportable segment | segment assets | at 2024-03-31 | ¥2.6bn |
| Aquareportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥60m |
| Livingreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥577m |
| Livingreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥493m |
| Livingreportable segment | employees | at 2024-03-31 | 325 pure |
| Livingreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥21.4bn |
| Livingreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥21.4bn |
| Livingreportable segment | segment assets | at 2024-03-31 | ¥7.1bn |
| Livingreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥645m |
| Medical And Industrial Gasreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥937m |
| Medical And Industrial Gasreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥492m |
| Medical And Industrial Gasreportable segment | employees | at 2024-03-31 | 226 pure |
| Medical And Industrial Gasreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥7.3bn |
| Medical And Industrial Gasreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥7.3bn |
| Medical And Industrial Gasreportable segment | segment assets | at 2024-03-31 | ¥4.8bn |
| Medical And Industrial Gasreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥350m |
| —segment total | capex | 2023-04-01 → 2024-03-31 | ¥1.6bn |
| —segment total | depreciation | 2023-04-01 → 2024-03-31 | ¥1.0bn |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥29.9bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥29.9bn |
| —segment total | segment assets | at 2024-03-31 | ¥14.4bn |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | ¥1.1bn |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | ¥7.0bn |
| Aquareportable segment | capex | 2022-04-01 → 2023-03-31 | ¥51m |
| Aquareportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥49m |
| Aquareportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥1.2bn |
| Aquareportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥1.2bn |
| Aquareportable segment | segment assets | at 2023-03-31 | ¥2.5bn |
| Aquareportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥38m |
| Livingreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥2.0bn |
| Livingreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥500m |
| Livingreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥22.0bn |
| Livingreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥22.0bn |
| Livingreportable segment | segment assets | at 2023-03-31 | ¥7.5bn |
| Livingreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥591m |
| Medical And Industrial Gasreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥674m |
| Medical And Industrial Gasreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥463m |
| Medical And Industrial Gasreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥7.4bn |
| Medical And Industrial Gasreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥7.4bn |
| Medical And Industrial Gasreportable segment | segment assets | at 2023-03-31 | ¥4.9bn |
| Medical And Industrial Gasreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥406m |
| —segment total | capex | 2022-04-01 → 2023-03-31 | ¥2.7bn |
| —segment total | depreciation | 2022-04-01 → 2023-03-31 | ¥1.0bn |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥30.6bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥30.6bn |
| —segment total | segment assets | at 2023-03-31 | ¥14.8bn |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | ¥1.0bn |
| Aquareportable segment | employees | at 2024-03-31 | 91 pure |
| Livingreportable segment | employees | at 2024-03-31 | 229 pure |
| Medical And Industrial Gasreportable segment | employees | at 2024-03-31 | 123 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,697
| Item | Context | Value | Unit |
|---|---|---|---|
| Increase in cash and cash equivalents from newly consolidated subsidiary cce | Prior1YearDuration | － | JPY |
| Increase in cash and cash equivalents from newly consolidated subsidiary cce | CurrentYearDuration | 223780000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 3540874000 | JPY |
| Cash and cash equivalents | CurrentYearInstant | 3611059000 | JPY |
| Number of consolidated subsidiaries | CurrentYearInstant | 9 | |
| Freightage expenses sga | Prior1YearDuration | 931044000 | JPY |
| Freightage expenses sga | CurrentYearDuration | 948032000 | JPY |
| Supplies and others sga | Prior1YearDuration | 922232000 | JPY |
| Supplies and others sga | CurrentYearDuration | 882464000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YearDuration | -11634000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYearDuration | -1700000 | JPY |
| Salaries sga | Prior1YearDuration | 2125781000 | JPY |
| Salaries sga | CurrentYearDuration | 2237807000 | JPY |
| Provision for directors bonuses sga | Prior1YearDuration | 27290000 | JPY |
| Provision for directors bonuses sga | CurrentYearDuration | 22900000 | JPY |
| Retirement benefit expenses sga | Prior1YearDuration | 105791000 | JPY |
| Retirement benefit expenses sga | CurrentYearDuration | 109484000 | JPY |
| Provision for directors retirement benefits sga | Prior1YearDuration | 34781000 | JPY |
| Provision for directors retirement benefits sga | CurrentYearDuration | 13191000 | JPY |
| Depreciation sga | Prior1YearDuration | 648334000 | JPY |
| Depreciation sga | CurrentYearDuration | 641330000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E02739-000LivingReportableSegmentsMember | 21994281000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E02739-000AquaReportableSegmentsMember | 1202351000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E02739-000MedicalAndIndustrialGasReportableSegmentsMember | 7438669000 | JPY |
| Revenues from external customers | Prior1YearDuration_ReportableSegmentsMember | 30635302000 | JPY |
| Revenues from external customers | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YearDuration | 30635302000 | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E02739-000LivingReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E02739-000AquaReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E02739-000MedicalAndIndustrialGasReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration | － | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E02739-000LivingReportableSegmentsMember | 21994281000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E02739-000AquaReportableSegmentsMember | 1202351000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E02739-000MedicalAndIndustrialGasReportableSegmentsMember | 7438669000 | JPY |
| Net sales | Prior1YearDuration_ReportableSegmentsMember | 30635302000 | JPY |
| Net sales | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1YearDuration | 30635302000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E02739-000LivingReportableSegmentsMember | 591196000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E02739-000AquaReportableSegmentsMember | 37541000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E02739-000MedicalAndIndustrialGasReportableSegmentsMember | 405973000 | JPY |
| Operating income | Prior1YearDuration_ReportableSegmentsMember | 1034710000 | JPY |
| Operating income | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Operating income | Prior1YearDuration | 1034710000 | JPY |
| Assets | Prior1YearInstant_jpcrp030000-asr_E02739-000LivingReportableSegmentsMember | 7516942000 | JPY |
| Assets | Prior1YearInstant_jpcrp030000-asr_E02739-000AquaReportableSegmentsMember | 2453332000 | JPY |
| Assets | Prior1YearInstant_jpcrp030000-asr_E02739-000MedicalAndIndustrialGasReportableSegmentsMember | 4868914000 | JPY |
| Assets | Prior1YearInstant_ReportableSegmentsMember | 14839189000 | JPY |
| Assets | Prior1YearInstant_ReconcilingItemsMember | 6972588000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |